Evidence map›Paper›PMID 35398993›Full record

ArticleJournal of extracellular vesicles2022

A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation.

Martin Wolf, Rodolphe W Poupardin, Patricia Ebner-Peking, André Cronemberger Andrade, Constantin Blöchl, Astrid Obermayer, Fausto Gueths Gomes, Balazs Vari, Nicole Maeding, Essi Eminger and 12 more

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 180 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 3 pooled it
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 3 syntheses or guidelines pooled it, 248 citations in OpenAlex.

  1. Systematic review of changes in extracellular vesicles associated with obstructive sleep apnoea: implications for diagnosis and treatment.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Martin WolfCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.ORCID 0000-0002-4795-8086
Rodolphe W PoupardinCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Patricia Ebner-PekingCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
André Cronemberger AndradeCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Constantin BlöchlDepartment of Biosciences, Paris Lodron University Salzburg, Salzburg, Austria.
Astrid ObermayerDepartment of Biosciences, Paris Lodron University Salzburg, Salzburg, Austria.
Fausto Gueths GomesCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Balazs VariCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Nicole MaedingCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Essi EmingerCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Heide-Marie BinderCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Anna M RaningerCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Sarah HochmannCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Gabriele BrachtlCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Andreas SpittlerCore Facility Flow Cytometry and Department of Surgery, Research Laboratories, Medical University of Vienna, Vienna, Austria.
Thomas HeuserVienna Biocentre Core Facilities, Vienna, Austria.
Racheli OfirPluristem Ltd., Haifa, Israel.
Christian G HuberDepartment of Biosciences, Paris Lodron University Salzburg, Salzburg, Austria.
Zami AbermanPluristem Ltd., Haifa, Israel.
Katharina SchallmoserDepartment of Transfusion Medicine and SCI-TReCS, PMU, Salzburg, Austria.
Hans-Dieter VolkBerlin Institute of Health at Charité - Universitätsmedizin, BIH Centre for Regenerative Therapies (BCRT), Berlin, Germany.
Dirk StrunkCell Therapy Institute, Spinal Cord Injury and Tissue Regeneration Centre Salzburg (SCI-TReCS), Paracelsus Medical University (PMU), Salzburg, Austria.
Paracelsus Medical University · ATUniversity of Salzburg · ATPluristem Therapeutics (Israel) · ILBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DEMedical University of Vienna · ATVienna Biocenter · AT

Funding

Austrian Science Fund W1213European Commission 731377European Commission 733006F 2000237-FIP "STEBS"Land Salzburg 20102-F2100572-FPREV-QuantLand Salzburg F2000237-FIPSTEBSLand Salzburg IWB/EFRE P1812596Land Salzburg WISS 2025 20102-F1900731-KZP EV-TT
6 · The paper itself

Abstract

Nanoparticles can acquire a plasma protein corona defining their biological identity. Corona functions were previously considered for cell-derived extracellular vesicles (EVs). Here we demonstrate that nano-sized EVs from therapy-grade human placental-expanded (PLX) stromal cells are surrounded by an imageable and functional protein corona when enriched with permissive technology. Scalable EV separation from cell-secreted soluble factors via tangential flow-filtration (TFF) and subtractive tandem mass-tag (TMT) proteomics revealed significant enrichment of predominantly immunomodulatory and proangiogenic proteins. Western blot, calcein-based flow cytometry, super-resolution and electron microscopy verified EV identity. PLX-EVs partly protected corona proteins from protease digestion. EVs significantly ameliorated human skin regeneration and angiogenesis in vivo, induced differential signalling in immune cells, and dose-dependently inhibited T cell proliferation in vitro. Corona removal by size-exclusion or ultracentrifugation abrogated angiogenesis. Re-establishing an artificial corona by cloaking EVs with fluorescent albumin as a model protein or defined proangiogenic factors was depicted by super-resolution microscopy, electron microscopy and zeta-potential shift, and served as a proof-of-concept. Understanding EV corona formation will improve rational EV-inspired nano-therapy design.

Indexed as

Extracellular VesiclesProtein CoronaFemaleHumansImmunomodulationPlacentaPregnancyProteomicsProtein CoronaangiogenesisEV coronaEV functionextracelular vesicleplacenta derived stromal cellstangential flow filtration

Identifiers

PMID35398993
PMCPMC8994701
OpenAlexW4223547694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.